메뉴 건너뛰기




Volumn 30, Issue 1, 2000, Pages 73-76

Unmet needs in the treatment of asthmatic children and adolescents: 2

Author keywords

Adolescents; Asthma; Children; Prevention; Therapy

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

EID: 0034078276     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (15)

References (9)
  • 1
    • 0028295289 scopus 로고
    • IgE determination in neonates is not suitable for general screening
    • Kjellman N-IM. IgE determination in neonates is not suitable for general screening. Ped Allergy Immunol 1994; 5:1-4.
    • (1994) Ped Allergy Immunol , vol.5 , pp. 1-4
    • Kjellman, N.-I.M.1
  • 2
    • 0029007501 scopus 로고
    • Compliance in asthma: A European perspective
    • Cochrane GM. Compliance in asthma: a European perspective. Eur Resp Rev 1995; 5:116-9.
    • (1995) Eur Resp Rev , vol.5 , pp. 116-119
    • Cochrane, G.M.1
  • 3
    • 0029787901 scopus 로고    scopus 로고
    • Important issues in childhood asthma
    • Pederson S. Important issues in childhood asthma. Eur Resp Rev 1996; 6:192-6.
    • (1996) Eur Resp Rev , vol.6 , pp. 192-196
    • Pederson, S.1
  • 4
    • 0343177506 scopus 로고    scopus 로고
    • Risk factors in the development of allergy
    • Schatz M, Zeiger R, Claman H.eds. Asthma and Immunological Diseases in Pregnancy and Early Infancy. Lenfant C, eds. New York: Marcel Dekker
    • Björkstén B, Kjellman M-IM. Risk factors in the development of allergy. In: Schatz M, Zeiger R, Claman H.eds. Asthma and Immunological Diseases in Pregnancy and Early Infancy. (Lenfant C, eds. Lung Biology in Health and Disease, Vol 110) New York: Marcel Dekker, 1997: 677-702.
    • (1997) Lung Biology in Health and Disease , vol.110 , pp. 677-702
    • Björkstén, B.1    Kjellman, M.-I.M.2
  • 5
    • 0005065215 scopus 로고    scopus 로고
    • Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: First results of ETAC
    • ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Ped Allergy Immunol 1998; 9:116-24.
    • (1998) Ped Allergy Immunol , vol.9 , pp. 116-124
  • 6
    • 0026578963 scopus 로고
    • Allergy prevention by maternal elimination diet during late pregnancy - A 5-year follow-up of a randomized study
    • Fäith-Magnusson K, Kjellman N-IM. Allergy prevention by maternal elimination diet during late pregnancy - a 5-year follow-up of a randomized study. J Allergy Clin Immunol 1992; 89:709-13.
    • (1992) J Allergy Clin Immunol , vol.89 , pp. 709-713
    • Fäith-Magnusson, K.1    Kjellman, N.-I.M.2
  • 7
    • 0030678565 scopus 로고    scopus 로고
    • Capacity of specific immunotherapy in prevention of allergic asthma in children: The preventive allergy treatment study (PAT)
    • Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma in children: the preventive allergy treatment study (PAT). J Invest Allergol Clin Immunol 1997; 7:369-70.
    • (1997) J Invest Allergol Clin Immunol , vol.7 , pp. 369-370
    • Valovirta, E.1
  • 8
    • 1842370350 scopus 로고    scopus 로고
    • Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteriods establishing therapy (FACET) International Study Group
    • Pauwels RA, Lofdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteriods Establishing Therapy (FACET) International Study Group. New Engl J Med 1997; 337:1405-11.
    • (1997) New Engl J Med , vol.337 , pp. 1405-1411
    • Pauwels, R.A.1    Lofdahl, C.G.2    Postma, D.S.3
  • 9
    • 0028264310 scopus 로고
    • Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
    • Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344:219-24.
    • (1994) Lancet , vol.344 , pp. 219-224
    • Greening, A.P.1    Ind, P.W.2    Northfield, M.3    Shaw, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.